000 | 01256 a2200325 4500 | ||
---|---|---|---|
005 | 20250514184155.0 | ||
264 | 0 | _c20040930 | |
008 | 200409s 0 0 eng d | ||
022 | _a1363-1950 | ||
024 | 7 |
_a10.1097/00075197-200405000-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoth, Stephen M | |
245 | 0 | 0 |
_aMyostatin: a therapeutic target for skeletal muscle wasting. _h[electronic resource] |
260 |
_bCurrent opinion in clinical nutrition and metabolic care _cMay 2004 |
||
300 |
_a259-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aMuscular Diseases _xdrug therapy |
650 | 0 | 4 | _aMyostatin |
650 | 0 | 4 |
_aRegeneration _xdrug effects |
650 | 0 | 4 | _aTranscription, Genetic |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xgenetics |
700 | 1 | _aWalsh, Sean | |
773 | 0 |
_tCurrent opinion in clinical nutrition and metabolic care _gvol. 7 _gno. 3 _gp. 259-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00075197-200405000-00004 _zAvailable from publisher's website |
999 |
_c14790798 _d14790798 |